Keyphrases
Non-alcoholic Fatty Liver Disease (NAFLD)
74%
Nonalcoholic Steatohepatitis
74%
Metabolic Syndrome
70%
Keishibukuryogan
51%
Kampo Medicine
41%
Monosodium Glutamate
40%
Kampo Formula
39%
Mouse Model
39%
Obesity
36%
Steatohepatitis
31%
Galectin-3 (Gal-3)
29%
Liver
25%
Kampo
25%
Hepatocellular Carcinoma
23%
Liver Inflammation
21%
Japan
20%
Insulin Resistance
19%
Intra-aortic Balloon Occlusion
19%
Endoscopic Hemostasis
19%
Liver Nodules
17%
Liver Injury
17%
Polyps
16%
Suzuki
14%
Scutellariae Radix
14%
Renal Failure
14%
Remnant Kidney Model
14%
Renal Injury
14%
University Hospital
14%
Male Mice
14%
Tsumura Suzuki Obese Diabetes Mouse
14%
Adverse Drug Events
14%
Oxidative Stress
13%
Lipid Metabolism
13%
Blood Pressure
13%
Visceral Fat
13%
Apoptosis
13%
Obesity Diabetes
12%
Knock-in Mouse Model
12%
Gene Expression
12%
Japanese Kampo Medicine
12%
Fibrosis
12%
Human Hepatocellular Carcinoma
11%
Pancreas
11%
Disease Progression
11%
Hypertension
11%
Diet-induced
11%
Macrophages
11%
Type 1 Diabetes Mellitus (T1DM)
11%
Diagnostic Criteria
10%
Kampo Formulation
10%
Medicine and Dentistry
Nonalcoholic Fatty Liver
94%
Kampo
75%
Keishi Bukuryo Gan
54%
Glutamate Sodium
39%
Steatohepatitis
33%
Hepatocellular Carcinoma
31%
Metabolic Syndrome
31%
Liver Injury
27%
Hepatitis
20%
Galectin 3
19%
Balloon Occlusion
19%
Endoscopic Hemostasis
19%
Polyp
19%
Diabetes
17%
Liver Nodule
17%
Fibrosis
14%
Renal Failure
14%
Kidney Injury
14%
Bleeding
14%
Adverse Drug Reaction
13%
Gene Expression
12%
Hyperlipidemia
12%
Blood Pressure
12%
Scutellariae Radix
12%
Diagnosis
11%
Diabetes Mellitus
10%
Oxidative Stress
10%
Skin Ulcer
9%
Controlled Clinical Trial
9%
Self-Diagnosis
9%
Inflammatory Cytokine
9%
Fatty Liver
9%
Duodenal Ulcer Bleeding
9%
Medication Error
9%
Influenza Vaccination
9%
Endothelial Function
9%
Medical Student
9%
Promoter Region
9%
Amino Acid
9%
Adenoma
9%
Choline
9%
Cowden Syndrome
9%
Dysplasia
9%
Reproductive Medicine
9%
Pancreas Carcinoma
9%
Surgery
9%
Hyperbaric Medicine
9%
Oxygen Therapy
9%
Vertigo
9%
Dizziness
9%
Pharmacology, Toxicology and Pharmaceutical Science
Nonalcoholic Fatty Liver
100%
Kampo Medicine (Drug)
84%
Metabolic Syndrome X
60%
Keishi Bukuryo Gan
41%
Mouse Model
32%
Liver Cell Carcinoma
30%
Galectin 3
29%
Hyperlipidemia
20%
Glutamate Sodium
20%
Liver Injury
20%
Leporidae
19%
Liver Nodule
17%
Disease
15%
Fibrosis
15%
Neoplasm
14%
Kidney Failure
14%
Kidney Injury
14%
Knockout Mouse
14%
Adverse Drug Reaction
14%
Leptin
13%
Scutellariae Radix
13%
Spontaneously Hypertensive Rat
12%
Adverse Event
12%
Insulin Resistance
11%
Diabetes Mellitus
10%
Tumor Necrosis Factor
10%
Pioglitazone
9%
Controlled Clinical Trial
9%
Fatty Liver
9%
Red Yeast Rice
9%
Mevinolin
9%
Medication Error
9%
Skin Ulcer
9%
Spirulina
9%
Choline
9%
Ob/Ob Mouse
9%
Mouse Mutant
9%
Cytokine
9%
Toxic Hepatitis
9%
Breast Cancer
9%
Shikonin
9%
Amino Acid
9%
Acute Pancreatitis
9%
Bile Acid
9%
Ceruletide
9%
Dizziness
9%
Liver Tumor
9%
Vertigo
9%
Influenza A Virus (H3N2)
9%
Messenger RNA
8%